The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus

References

• Zheng P, Li Z, Zhou Z. Gut microbiome in type 1 diabetes: a comprehensive review. Diabetes Metab Res Rev. 2018;34(7):e3043. doi:10.1002/dmrr.3043
   PubMed Web of Science ®Google Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11(1):46. doi:10.1186/1741-7015-11-46
   PubMed Web of Science ®Google Scholar
• de Goffau MC, Fuentes S, van den Bogert B, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014;57(8):1569–1577. doi:10.1007/s00125-014-3274-0
   PubMed Web of Science ®Google Scholar
• Desselberger U. The mammalian intestinal microbiome: composition, interaction with the immune system, significance for vaccine efficacy, and potential for disease therapy. Pathogens. 2018;7(3):57. doi:10.3390/pathogens7030057
   PubMed Web of Science ®Google Scholar
• Clavel T, Lagkouvardos I, Blaut M, Stecher B. The mouse gut microbiome revisited: from complex diversity to model ecosystems. Int J Med Microbiol. 2016;306(5):316–327. doi:10.1016/j.ijmm.2016.03.002
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107(26):11971–11975. doi:10.1073/pnas.1002601107
   PubMed Web of Science ®Google Scholar
• Vatanen T, Kostic AD, d’Hennezel E, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165(4):842–853. doi:10.1016/j.cell.2016.04.007
   PubMed Web of Science ®Google Scholar
• Mullaney JA, Stephens JE, Costello ME, et al. Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota. Microbiome. 2018;6(1):35. doi:10.1186/s40168-018-0417-4
   Web of Science ®Google Scholar
• Silverman M, Kua L, Tanca A, et al. Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny. Proc Natl Acad Sci U S A. 2017;114(36):9671–9676. doi:10.1073/pnas.1712280114
   PubMed Web of Science ®Google Scholar
• Hu Y, Peng J, Li F, Wong FS, Wen L. Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice. Sci Rep. 2018;8(1):15451. doi:10.1038/s41598-018-33571-z
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Siljander H, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015;17(2):260–273. doi:10.1016/j.chom.2015.01.001
   PubMed Web of Science ®Google Scholar
• Roth-Schulze AJ, Penno M, Ngui KM, et al. Type 1 diabetes in pregnancy is associated with distinct changes in the composition and function of the gut microbiome. Microbiome. 2021;9(1):167. doi:10.1186/s40168-021-01104-y
   Web of Science ®Google Scholar
• Kayama H, Okumura R, Takeda K. Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu Rev Immunol. 2020;38(1):23–48. doi:10.1146/annurev-immunol-070119-115104
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen F, Wu W, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018;11(3):752–762. doi:10.1038/mi.2017.118
   PubMed Web of Science ®Google Scholar
• Liang W, Enée E, Andre-Vallee C, Falcone M, Sun J, Diana J. Intestinal cathelicidin antimicrobial peptide shapes a protective neonatal gut microbiota against pancreatic autoimmunity. Gastroenterology. 2021;162(4):1288–1302.e16. doi:10.1053/j.gastro.2021.12.272
   PubMed Web of Science ®Google Scholar
• Chung LK, Raffatellu M. G.I. pros: antimicrobial defense in the gastrointestinal tract. Semin Cell Dev Biol. 2019;88:129–137. doi:10.1016/j.semcdb.2018.02.001
   PubMed Web of Science ®Google Scholar
• Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia. 2010;53(4):741–748. doi:10.1007/s00125-009-1626-y
   PubMed Web of Science ®Google Scholar
• Neu J, Reverte CM, Mackey AD, et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr. 2005;40(5):589–595. doi:10.1097/01.MPG.0000159636.19346.C1
   PubMed Web of Science ®Google Scholar
• Miranda M, Oliveira RP, Torres L, et al. Frontline science: abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes. J Leukoc Biol. 2019;106(3):513–529. doi:10.1002/JLB.3HI0119-024RR
   Web of Science ®Google Scholar
• Huang J, Pearson JA, Peng J, et al. Gut microbial metabolites alter IgA immunity in type 1 diabetes. JCI Insight. 2020;5(10). doi:10.1172/jci.insight.135718.
   Web of Science ®Google Scholar
• Knip M, Siljander H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol. 2016;12(3):154–167. doi:10.1038/nrendo.2015.218
   PubMed Web of Science ®Google Scholar
• Lv W, Graves DT, He L, et al. Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus. Theranostics. 2020;10(14):6500–6516. doi:10.7150/thno.44113
   Web of Science ®Google Scholar
• Costa FR, Françozo MC, de Oliveira GG, et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. J Exp Med. 2016;213(7):1223–1239. doi:10.1084/jem.20150744
   PubMed Web of Science ®Google Scholar
• Jaakkola I, Jalkanen S, Hänninen A. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice. Eur J Immunol. 2003;33(12):3255–3264. doi:10.1002/eji.200324405
   PubMed Web of Science ®Google Scholar
• Liu X, Tong X, Zou Y, et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet. 2022;54(1):52–61. doi:10.1038/s41588-021-00968-y
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9
   PubMed Web of Science ®Google Scholar
• Kim CH. Microbiota or short-chain fatty acids: which regulates diabetes. Cell Mol Immunol. 2018;15(2):88–91. doi:10.1038/cmi.2017.57
   PubMed Web of Science ®Google Scholar
• Scott SA, Fu J, Chang PV. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc Natl Acad Sci USA. 2020;117(32):19376–19387. doi:10.1073/pnas.2000047117
   PubMed Web of Science ®Google Scholar
• Lamichhane S, Kemppainen E, Trošt K, et al. Circulating metabolites in progression to islet autoimmunity and type 1 diabetes. Diabetologia. 2019;62(12):2287–2297. doi:10.1007/s00125-019-04980-0
   PubMed Web of Science ®Google Scholar
• Lamichhane S, Ahonen L, Dyrlund TS, et al. A longitudinal plasma lipidomics dataset from children who developed islet autoimmunity and type 1 diabetes. Sci Data. 2018;5(1):180250. doi:10.1038/sdata.2018.250
   Web of Science ®Google Scholar
• Sobczak A, Pitt SJ, Smith TK, Ajjan RA, Stewart AJ. Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(1):158823. doi:10.1016/j.bbalip.2020.158823
   Web of Science ®Google Scholar
• Mathew AV, Jaiswal M, Ang L, Michailidis G, Pennathur S, Pop-Busui R. Impaired amino acid and TCA metabolism and cardiovascular autonomic neuropathy progression in type 1 diabetes. Diabetes. 2019;68(10):2035–2044. doi:10.2337/db19-0145
   Web of Science ®Google Scholar
• Winther SA, Henriksen P, Vogt JK, et al. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria. Diabetologia. 2020;63(12):2713–2724. doi:10.1007/s00125-020-05260-y
   Web of Science ®Google Scholar
• Buchwald P, Tamayo-Garcia A, Ramamoorthy S, Garcia-Contreras M, Mendez AJ, Ricordi C. Comprehensive metabolomics study to assess longitudinal biochemical changes and potential early biomarkers in nonobese diabetic mice that progress to diabetes. J Proteome Res. 2017;16(10):3873–3890. doi:10.1021/acs.jproteome.7b00512
   Web of Science ®Google Scholar
• Mariño E, Richards JL, McLeod KH, et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol. 2017;18(5):552–562. doi:10.1038/ni.3713
   PubMed Web of Science ®Google Scholar
• Tanca A, Palomba A, Fraumene C, Manghina V, Silverman M, Uzzau S. Clostridial butyrate biosynthesis enzymes are significantly depleted in the gut microbiota of nonobese diabetic mice. mSphere. 2018;3(5). doi:10.1128/mSphere.00492-18
   Web of Science ®Google Scholar
• Tabibian JH, Kenderian SS. The microbiome and immune regulation after transplantation. Transplantation. 2017;101(1):56–62. doi:10.1097/TP.0000000000001444
   Web of Science ®Google Scholar
• Tai N, Peng J, Liu F, et al. Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med. 2016;213(10):2129–2146. doi:10.1084/jem.20160526
   PubMed Web of Science ®Google Scholar
• Sorini C, Cosorich I, Lo Conte M, et al. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc Natl Acad Sci USA. 2019;116(30):15140–15149. doi:10.1073/pnas.1814558116
   PubMed Web of Science ®Google Scholar
• Sun M, Wu W, Chen L, et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9(1):3555. doi:10.1038/s41467-018-05901-2
   PubMed Web of Science ®Google Scholar
• Huang J, Tan Q, Tai N, et al. IL-10 deficiency accelerates type 1 diabetes development via modulation of innate and adaptive immune cells and gut microbiota in BDC2.5 NOD mice. Front Immunol. 2021;12:702955. doi:10.3389/fimmu.2021.702955
   Web of Science ®Google Scholar
• Neuman V, Cinek O, Funda DP, et al. Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor. Diabetologia. 2019;62(7):1291–1296. doi:10.1007/s00125-019-4869-2
   PubMed Web of Science ®Google Scholar
• King C, Sarvetnick N, von Herrath M. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One. 2011;6(2):e17049. doi:10.1371/journal.pone.0017049
   Web of Science ®Google Scholar
• Hänninen A, Toivonen R, Pöysti S, et al. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 2018;67(8):1445–1453. doi:10.1136/gutjnl-2017-314508
   PubMed Web of Science ®Google Scholar
• Zhang XS, Yin YS, Wang J, et al. Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice. Cell Host Microbe. 2021;29(8):1249–1265.e9. doi:10.1016/j.chom.2021.06.014
   PubMed Web of Science ®Google Scholar
• Bell KJ, Saad S, Tillett BJ, et al. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome. 2022;10(1):9. doi:10.1186/s40168-021-01193-9
   PubMed Web of Science ®Google Scholar
• Sun J, Furio L, Mecheri R, et al. Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity. 2015;43(2):304–317. doi:10.1016/j.immuni.2015.07.013
   PubMed Web of Science ®Google Scholar
• Jia L, Cao M, Chen H, et al. Butyrate ameliorates antibiotic-driven type 1 diabetes in the female offspring of nonobese diabetic mice. J Agric Food Chem. 2020;68(10):3112–3120. doi:10.1021/acs.jafc.9b07701
   PubMed Web of Science ®Google Scholar
• Jacob N, Jaiswal S, Maheshwari D, et al. Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Sci Rep. 2020;10(1):19120. doi:10.1038/s41598-020-76109-y
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107–118. doi:10.1016/j.cell.2005.05.007
   PubMed Web of Science ®Google Scholar
• Martin-Gallausiaux C, Béguet-Crespel F, Marinelli L, et al. Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells. Sci Rep. 2018;8(1):9742. doi:10.1038/s41598-018-28048-y
   PubMed Web of Science ®Google Scholar
• Hao F, Tian M, Zhang X, et al. Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation. Proc Natl Acad Sci U S A. 2021;118(22):22. doi:10.1073/pnas.2014681118
   Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337–341. doi:10.1126/science.1198469
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–498. doi:10.1016/j.cell.2009.09.033
   PubMed Web of Science ®Google Scholar
• Ladinsky MS, Araujo LP, Zhang X, et al. Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis. Science. 2019;363(6431):6431. doi:10.1126/science.aat4042
   Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455. doi:10.1038/nature12726
   PubMed Web of Science ®Google Scholar
• Yang W, Yu T, Huang X, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457. doi:10.1038/s41467-020-18262-6
   PubMed Web of Science ®Google Scholar
• Vaarala O. Is the origin of type 1 diabetes in the gut. Immunol Cell Biol. 2012;90(3):271–276. doi:10.1038/icb.2011.115
   PubMed Web of Science ®Google Scholar
• Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes. Diabetologia. 2006;49(9):2105–2108. doi:10.1007/s00125-006-0334-0
   Web of Science ®Google Scholar
• Serena G, Camhi S, Sturgeon C, Yan S, Fasano A. The role of gluten in celiac disease and type 1 diabetes. Nutrients. 2015;7(9):7143–7162. doi:10.3390/nu7095329
   PubMed Web of Science ®Google Scholar
• Raman M, Ambalam P, Kondepudi KK, et al. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes. 2013;4(3):181–192. doi:10.4161/gmic.23919
   PubMed Web of Science ®Google Scholar
• Mazlyn MM, Nagarajah LH, Fatimah A, Norimah AK, Goh KL. Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study. J Gastroenterol Hepatol. 2013;28(7):1141–1147. doi:10.1111/jgh.12168
   Web of Science ®Google Scholar
• Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hänninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes. 2010;59(9):2237–2246. doi:10.2337/db10-0147
   Web of Science ®Google Scholar
• Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050. doi:10.3389/fmicb.2015.01050
   PubMed Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041
   PubMed Web of Science ®Google Scholar
• Sun Y, He Y, Wang F, Zhang H, de Vos P, Sun J. Low-methoxyl lemon pectin attenuates inflammatory responses and improves intestinal barrier integrity in caerulein-induced experimental acute pancreatitis. Mol Nutr Food Res. 2017;61(4):1600885. doi:10.1002/mnfr.201600885
   Web of Science ®Google Scholar
• Sahasrabudhe NM, Beukema M, Tian L, et al. Dietary fiber pectin directly blocks toll-like receptor 2-1 and prevents doxorubicin-induced ileitis. Front Immunol. 2018;9:383. doi:10.3389/fimmu.2018.00383
   PubMed Web of Science ®Google Scholar
• Komaroff AL. The microbiome and risk for obesity and diabetes. JAMA. 2017;317(4):355–356. doi:10.1001/jama.2016.20099
   PubMed Web of Science ®Google Scholar
• Wu C, Pan LL, Niu W, et al. Modulation of gut microbiota by low methoxyl pectin attenuates type 1 diabetes in non-obese diabetic mice. Front Immunol. 2019;10:1733. doi:10.3389/fimmu.2019.01733
   PubMed Web of Science ®Google Scholar
• Gudi R, Perez N, Johnson BM, et al. Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes. Immunology. 2019;157(1):70–85. doi:10.1111/imm.13048
   PubMed Web of Science ®Google Scholar
• Shi CW, Cheng MY, Yang X, et al. Probiotic lactobacillus rhamnosus gg promotes mouse gut microbiota diversity and T cell differentiation. Front Microbiol. 2020;11:607735. doi:10.3389/fmicb.2020.607735
   Web of Science ®Google Scholar
• Yadav R, Dey DK, Vij R, Meena S, Kapila R, Kapila S. Evaluation of anti-diabetic attributes of Lactobacillus rhamnosus MTCC: 5957, Lactobacillus rhamnosus MTCC: 5897 and Lactobacillus fermentum MTCC: 5898 in streptozotocin induced diabetic rats. Microb Pathog. 2018;125:454–462. doi:10.1016/j.micpath.2018.10.015
   PubMed Web of Science ®Google Scholar
• Chung PH, Wu YY, Chen PH, Fung CP, Hsu CM, Chen LW. Lactobacillus salivarius reverse diabetes-induced intestinal defense impairment in mice through non-defensin protein. J Nutr Biochem. 2016;35:48–57. doi:10.1016/j.jnutbio.2016.05.013
   Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232–236. doi:10.1038/nature12331
   PubMed Web of Science ®Google Scholar
• Dolpady J, Sorini C, Di Pietro C, et al. Oral probiotic VSL#3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2,3-dioxygenase-enriched tolerogenic intestinal environment. J Diabetes Res. 2016;2016:7569431. doi:10.1155/2016/7569431
   PubMed Web of Science ®Google Scholar
• Uusitalo U, Liu X, Yang J, et al. Association of early exposure of probiotics and islet autoimmunity in the TEDDY study. JAMA Pediatr. 2016;170(1):20–28. doi:10.1001/jamapediatrics.2015.2757
   PubMed Web of Science ®Google Scholar
• Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: a randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabetes. 2021;22(7):1014–1022. doi:10.1111/pedi.13244
   PubMed Web of Science ®Google Scholar
• Ho J, Nicolucci AC, Virtanen H, et al. Effect of prebiotic on microbiota, intestinal permeability, and glycemic control in children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(10):4427–4440. doi:10.1210/jc.2019-00481
   PubMed Web of Science ®Google Scholar
• Zare Javid A, Aminzadeh M, Haghighi-Zadeh MH, Jamalvandi M. The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. a placebo-controlled, double-blind, randomized clinical trial. Diabetes Metab Syndr Obes. 2020;13:607–617. doi:10.2147/DMSO.S238867
   PubMed Web of Science ®Google Scholar
• Savilahti E, Härkönen T, Savilahti EM, Kukkonen K, Kuitunen M, Knip M. Probiotic intervention in infancy is not associated with development of beta cell autoimmunity and type 1 diabetes. Diabetologia. 2018;61(12):2668–2670. doi:10.1007/s00125-018-4738-4
   Web of Science ®Google Scholar
• Groele L, Szajewska H, Szalecki M, et al. Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial. BMJ Open Diabetes Res Care. 2021;9(1):e001523. doi:10.1136/bmjdrc-2020-001523
   Web of Science ®Google Scholar
• Beyerlein A, Liu X, Uusitalo UM, et al. Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study. Am J Clin Nutr. 2015;102(2):345–352. doi:10.3945/ajcn.115.108159
   Web of Science ®Google Scholar
• Tamma PD, Miller MA, Cosgrove SE. Rethinking how antibiotics are prescribed: incorporating the 4 moments of antibiotic decision making into clinical practice. JAMA. 2019;321(2):139–140. doi:10.1001/jama.2018.19509
   Web of Science ®Google Scholar
• Wan QY, Zhao R, Wang Y, Wu Y, Wu XT. Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants. Gut. 2020;69(11):2059–2060. doi:10.1136/gutjnl-2020-320826
   Web of Science ®Google Scholar
• Donovan BM, Abreo A, Ding T, et al. Dose, timing, and type of infant antibiotic use and the risk of childhood asthma. Clin Infect Dis. 2020;70(8):1658–1665. doi:10.1093/cid/ciz448
   PubMed Web of Science ®Google Scholar
• Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65(11):1906–1915. doi:10.1136/gutjnl-2016-312297
   PubMed Web of Science ®Google Scholar
• Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004;47(2):225–239. doi:10.1007/s00125-003-1297-z
   PubMed Web of Science ®Google Scholar
• Blanter M, Sork H, Tuomela S, Flodström-Tullberg M. Genetic and environmental interaction in type 1 diabetes: a relationship between genetic risk alleles and molecular traits of enterovirus infection. Curr Diab Rep. 2019;19(9):82. doi:10.1007/s11892-019-1192-8
   Web of Science ®Google Scholar
• Guberski DL, Thomas VA, Shek WR, et al. Induction of type I diabetes by Kilham’s rat virus in diabetes-resistant BB/Wor rats. Science. 1991;254(5034):1010–1013. doi:10.1126/science.1658938
   Web of Science ®Google Scholar
• Needell JC, Brown MN, Zipris D. Involvement of adipose tissue inflammation and dysfunction in virus-induced type 1 diabetes. J Endocrinol. 2018;238(1):61–75. doi:10.1530/JOE-18-0131
   PubMed Web of Science ®Google Scholar
• Hara N, Alkanani AK, Ir D, et al. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J Immunol. 2012;189(8):3805–3814. doi:10.4049/jimmunol.1201257
   PubMed Web of Science ®Google Scholar
• Brown K, Godovannyi A, Ma C, et al. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. ISME J. 2016;10(2):321–332. doi:10.1038/ismej.2015.114
   PubMed Web of Science ®Google Scholar
• Livanos AE, Greiner TU, Vangay P, et al. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol. 2016;1(11):16140. doi:10.1038/nmicrobiol.2016.140
   PubMed Web of Science ®Google Scholar
• Hu Y, Jin P, Peng J, Zhang X, Wong FS, Wen L. Different immunological responses to early-life antibiotic exposure affecting autoimmune diabetes development in NOD mice. J Autoimmun. 2016;72:47–56. doi:10.1016/j.jaut.2016.05.001
   PubMed Web of Science ®Google Scholar
• Candon S, Perez-Arroyo A, Marquet C, et al. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS One. 2015;10(5):e0125448. doi:10.1371/journal.pone.0125448
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Ajami NJ, O’Brien JL, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562(7728):583–588. doi:10.1038/s41586-018-0617-x
   PubMed Web of Science ®Google Scholar
• Nadimpalli ML, Bourke CD, Robertson RC, Delarocque-Astagneau E, Manges AR, Pickering AJ. Can breastfeeding protect against antimicrobial resistance. BMC Med. 2020;18(1):392. doi:10.1186/s12916-020-01862-w
   Web of Science ®Google Scholar
• Karav S, Le Parc A, Leite Nobrega de Moura Bell JM, et al. Oligosaccharides released from milk glycoproteins are selective growth substrates for infant-associated bifidobacteria. Appl Environ Microbiol. 2016;82(12):3622–3630. doi:10.1128/AEM.00547-16
   PubMed Web of Science ®Google Scholar
• Kong C, Faas MM, de Vos P, Akkerman R. Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier. Food Funct. 2020;11(11):9445–9467. doi:10.1039/D0FO01700K
   Web of Science ®Google Scholar
• Chleilat F, Klancic T, Ma K, Schick A, Nettleton JE, Reimer RA. Human milk oligosaccharide supplementation affects intestinal barrier function and microbial composition in the gastrointestinal tract of young Sprague Dawley rats. Nutrients. 2020;12(5):1532. doi:10.3390/nu12051532
   Web of Science ®Google Scholar
• Vatanen T, Franzosa EA, Schwager R, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562(7728):589–594. doi:10.1038/s41586-018-0620-2
   PubMed Web of Science ®Google Scholar
• Atyeo C, Alter G. The multifaceted roles of breast milk antibodies. Cell. 2021;184(6):1486–1499. doi:10.1016/j.cell.2021.02.031
   PubMed Web of Science ®Google Scholar
• Ribo S, Sánchez-Infantes D, Martinez-Guino L, et al. Increasing breast milk betaine modulates Akkermansia abundance in mammalian neonates and improves long-term metabolic health. Sci Transl Med. 2021;13:587. doi:10.1126/scitranslmed.abb0322
   Web of Science ®Google Scholar
• Bode L, Raman AS, Murch SH, Rollins NC, Gordon JI. Understanding the mother-breastmilk-infant “triad”. Science. 2020;367(6482):1070–1072. doi:10.1126/science.aaw6147
   PubMed Web of Science ®Google Scholar
• Cardwell CR, Stene LC, Ludvigsson J, et al. Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care. 2012;35(11):2215–2225. doi:10.2337/dc12-0438
   PubMed Web of Science ®Google Scholar
• Hall K, Frederiksen B, Rewers M, Norris JM. Daycare attendance, breastfeeding, and the development of type 1 diabetes: the diabetes autoimmunity study in the young. Biomed Res Int. 2015;2015:203947. doi:10.1155/2015/203947
   Web of Science ®Google Scholar
• Sane F, Scuotto A, Pierrat V, Kacet N, Hober D, Romond MB. Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice. J Nutr Biochem. 2018;62:108–122. doi:10.1016/j.jnutbio.2018.08.017
   Web of Science ®Google Scholar
• Xiao L, Van’t Land B, Engen PA, et al. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Sci Rep. 2018;8(1):3829. doi:10.1038/s41598-018-22052-y
   PubMed Web of Science ®Google Scholar
• Lampousi AM, Carlsson S, Löfvenborg JE. Dietary factors and risk of islet autoimmunity and type 1 diabetes: a systematic review and meta-analysis. EBioMedicine. 2021;72:103633. doi:10.1016/j.ebiom.2021.103633
   PubMed Web of Science ®Google Scholar
• Moon JH, Kim H, Kim H, et al. Lactation improves pancreatic β cell mass and function through serotonin production. Sci Transl Med. 2020;12(541):541. doi:10.1126/scitranslmed.aay0455
   Web of Science ®Google Scholar
• Ye L, Li L, Wan B, et al. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther. 2017;8(1):90. doi:10.1186/s13287-017-0542-1
   Web of Science ®Google Scholar
• Luo Y, Cheng YW, Yu CY, et al. Effects of hyaluronic acid on differentiation of human amniotic epithelial cells and cell-replacement therapy in type 1 diabetic mice. Exp Cell Res. 2019;384(2):111642. doi:10.1016/j.yexcr.2019.111642
   Web of Science ®Google Scholar
• Pixley JS. Mesenchymal stem cells to treat type 1 diabetes. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165315. doi:10.1016/j.bbadis.2018.10.033
   Web of Science ®Google Scholar
• Li L, Hui H, Jia X, et al. Infusion with human bone marrow-derived mesenchymal stem cells improves β-cell function in patients and non-obese mice with severe diabetes. Sci Rep. 2016;6(1):37894. doi:10.1038/srep37894
   Web of Science ®Google Scholar
• Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013;2013:130763. doi:10.1155/2013/130763
   PubMed Web of Science ®Google Scholar
• Domouky AM, Hegab AS, Al-Shahat A, Raafat N. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus. Int J Biochem Cell Biol. 2017;87:77–85. doi:10.1016/j.biocel.2017.03.018
   PubMed Web of Science ®Google Scholar
• Nojehdehi S, Soudi S, Hesampour A, Rasouli S, Soleimani M, Hashemi SM. Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes. J Cell Biochem. 2018;119(11):9433–9443. doi:10.1002/jcb.27260
   PubMed Web of Science ®Google Scholar
• Mahdipour E, Salmasi Z, Sabeti N. Potential of stem cell-derived exosomes to regenerate β islets through Pdx-1 dependent mechanism in a rat model of type 1 diabetes. J Cell Physiol. 2019;234(11):20310–20321. doi:10.1002/jcp.28631
   PubMed Web of Science ®Google Scholar
• Sabry D, Marzouk S, Zakaria R, Ibrahim HA, Samir M. The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats. Biotechnol Lett. 2020;42(8):1597–1610. doi:10.1007/s10529-020-02908-y
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493–507. doi:10.1038/s41581-018-0023-5
   PubMed Web of Science ®Google Scholar
• Ikarashi S, Tsuchiya A, Kawata Y, et al. Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model. Biores Open Access. 2019;8(1):185–199. doi:10.1089/biores.2019.0022
   Web of Science ®Google Scholar
• Sun J, Ding X, Liu S, Duan X, Liang H, Sun T. Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats. Stem Cell Res Ther. 2020;11(1):384. doi:10.1186/s13287-020-01902-5
   PubMed Web of Science ®Google Scholar
• Traversi D, Rabbone I, Scaioli G, et al. Risk factors for type 1 diabetes, including environmental, behavioural and gut microbial factors: a case-control study. Sci Rep. 2020;10(1):17566. doi:10.1038/s41598-020-74678-6
   Web of Science ®Google Scholar
• Tang Q, Jin G, Wang G, et al. Current sampling methods for gut microbiota: a call for more precise devices. Front Cell Infect Microbiol. 2020;10:151. doi:10.3389/fcimb.2020.00151
   PubMed Web of Science ®Google Scholar
• Thakkar UG, Trivedi HL, Vanikar AV, Dave SD. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy. 2015;17(7):940–947. doi:10.1016/j.jcyt.2015.03.608
   Web of Science ®Google Scholar
• Ulyanova O, Askarov M, Kozina L, et al. Autologous mesenchymal stem cell transplant in patients with type 1 diabetes mellitus. Exp Clin Transplant. 2019;17(Suppl 1):236–238. doi:10.6002/ect.MESOT2018.P100
   Web of Science ®Google Scholar
• Ludvigsson J. Autoantigen treatment in type 1 diabetes: unsolved questions on how to select autoantigen and administration route. Int J Mol Sci. 2020;21(5):1598. doi:10.3390/ijms21051598
   Web of Science ®Google Scholar
• Yu H, Paiva R, Flavell RA. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective. Immunology. 2018;153(2):161–170. doi:10.1111/imm.12867
   Web of Science ®Google Scholar
• Rapini N, Schiaffini R, Fierabracci A. Immunotherapy strategies for the prevention and treatment of distinct stages of type 1 diabetes: an overview. Int J Mol Sci. 2020;21(6):2103. doi:10.3390/ijms21062103
   Web of Science ®Google Scholar
• Wang Y, Gao X, Zhang X, et al. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease. Gut Microbes. 2021;13(1):1–18. doi:10.1080/19490976.2021.1900996
   PubMed Web of Science ®Google Scholar
• Shi Y, Zheng W, Yang K, et al. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020;217(5). doi:10.1084/jem.20192282.
   Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes. 2005;54(1):92–99. doi:10.2337/diabetes.54.1.92
   PubMed Web of Science ®Google Scholar
• Shimokawa C, Kato T, Takeuchi T, et al. CD8(+) regulatory T cells are critical in prevention of autoimmune-mediated diabetes. Nat Commun. 2020;11(1):1922. doi:10.1038/s41467-020-15857-x
   PubMed Web of Science ®Google Scholar
• Yu H, Gagliani N, Ishigame H, et al. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc Natl Acad Sci USA. 2017;114(39):10443–10448. doi:10.1073/pnas.1705599114
   PubMed Web of Science ®Google Scholar
• Chhabra P, Spano AJ, Bowers D, et al. Evidence for the role of the cecal microbiome in maintenance of immune regulation and homeostasis. Ann Surg. 2018;268(3):541–549. doi:10.1097/SLA.0000000000002930
   PubMed Web of Science ®Google Scholar